Photo: Reuters
Donald Trump summoned the head of the U.S. vaccine regulator to the White House amid frustration that America had not moved faster with approval.
The U.S. president was said to be livid that the Food and Drug Administration (FDA) had yet to approve the Pfizer/BioNTech, having hoped the U.S. would be the first country to do so.
On Tuesday morning, amid suggestions the U.K. was close to approval, the in-person presence of Dr Stephen Hahn, commissioner of the FDA, was requested by Mark Meadows, Mr Trump's chief of staff. There had been speculation that Mr Trump would fire him but, after the 90-minute meeting, the FDA said that "Dr Hahn remains FDA commissioner".
The FDA has been reviewing thousands of pages of technical information on the Pfizer and Moderna vaccines as it deliberates whether to authorise "emergency use" for high-risk groups.
It has scheduled public meetings for December 10 and 17 to review the vaccines, and is expected to make decisions before the end of the year.
Pfizer applied for emergency use authorisation on November 20.
Read more from the original article:
https://news.yahoo.com/donald-...
免責事項：本記事で述べられている見解は著者の見解のみであり、Followmeの公式見解を反映するものではありません。Followmeは、提供された情報の正確性、完全性、信頼性について一切責任を負いません。また、書面で明示的に記載されている場合を除き、本記事の内容に基づいて行われたいかなる行動についても責任を負いません。
古いコメントはありません。ソファをつかむ最初のものになりましょう。